Johnson & Johnson reported Q2 FY 2016 earnings of $1.74 per share (versus $1.71 in Q2 FY 2015), beating analysts' consensus estimate of $1.68.
The company's quarterly revenues amounted to $18.482 bln (+3.9% y/y), beating analysts' consensus estimate of $17.986 bln.
JNJ rose to $126.01 (+2.33%) in pre-market trading.